Bringing doctors together

or

A free, private network for verified physicians

  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Hyperaldosteronism Remission after Extended Aldosterone Synthase Inhibition

    Nov 7, 2026DOI: 10.1056/nejmc2611265CorrespondenceNEJM

    Written by: Morris J. Brown, F.R.S., F.Med.Sci.Adina F. Turcu, M.D.Ramin Sam, M.D.Lawrence S. Kirschner, M.D., Ph.D.Oksana Hamidi, D.O.Aysegul Eren, M.D.Anat Ben-Shlomo, M.D.Wenyu Huang, M.D.Irina Bancos, M.D.Amir H. Hamrahian, M.D.Mason W. Freeman, M.D.

    Summary

    Among patients with hypertension due to primary aldosteronism, reductions in blood pressure and the aldosterone-to-renin ratio persisted for 2 years after completion of an extended course of aldosterone synthase inhibition.
    TNThe New England Journal of Medicine

    The New England Journal of Medicine

    Official Account
    https://www.nejm.org/
    nejm